Home LiteratureArticle Details
PMID: 8871552 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription.

Nucleic acids research ·Vol. 24 ·No. 19 ·1996-10-01 ·Pages 3733-8

Bohjanen PR, Colvin RA, Puttaraju M, Been MD, Garcia-Blanco MA

Abstract

Linear TAR RNA has previously been used as a decoy to inhibit HIV-1 transcription in vitro and HIV-1 replication in vivo. A 48 nucleotide circular RNA containing the stem, bulge and loop of the HIV-1 TAR element was synthesized using the self-splicing activity of a group I permuted intron-exon and was tested for its ability to function as a TAR decoy in vitro. This small circular TAR molecule was exceptionally stable in HeLa nuclear extracts, whereas a similar linear TAR molecule was rapidly degraded. The TAR circle bound specifically to Tfr38, a peptide containing the TAR-binding region of Tat. The ability of Tat to trans-activate transcription from the HIV-1 promoter in vitro was efficiently inhibited by circular TAR RNA but not by TAR circles that contained either bulge or loop mutations. TAR circles did not inhibit transactivation exclusively by binding to Tat since this inhibition was not reversed by adding excess Tat to the transcription reaction. Together, these data suggest that TAR circles act as decoys that inhibit transactivation by binding to Tat and at least one cellular factor. These data also demonstrate the utility of small circular RNA molecules as tools for biochemical studies.

MeSH Terms
Exons Gene Products, tat/antagonists & inhibitors,physiology HIV Long Terminal Repeat/genetics HIV-1/genetics HeLa Cells Humans Introns RNA/physiology RNA Splicing RNA, Circular Transcriptional Activation/physiology tat Gene Products, Human Immunodeficiency Virus
Chemicals
Gene Products, tat RNA, Circular tat Gene Products, Human Immunodeficiency Virus RNA
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bohjanen P R
Division of Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA.
Colvin R A
Puttaraju M
Been M D
Garcia-Blanco M A
References (49)
49 references, click to expand
  1. Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1990 May;87(9):3624-8 PMID: 2333305
  2. Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat.
    J Virol. 1995 Oct;69(10):6572-6 PMID: 7666561
  3. Trans-activation by HIV-1 Tat via a heterologous RNA binding protein.
    Cell. 1990 Aug 24;62(4):769-76 PMID: 2117500
  4. Fragments of the HIV-1 Tat protein specifically bind TAR RNA.
    Science. 1990 Sep 14;249(4974):1281-5 PMID: 2205002
  5. Structural features of an RNA containing the CUGGGA loop of the human immunodeficiency virus type 1 trans-activation response element.
    Biochemistry. 1993 Feb 2;32(4):1105-12 PMID: 8424939
  6. Design and synthesis of RNA miniduplexes via a synthetic linker approach.
    Biochemistry. 1993 Feb 23;32(7):1751-8 PMID: 7679923
  7. Rotational symmetry in ribonucleotide strand requirements for binding of HIV-1 Tat protein to TAR RNA.
    Nucleic Acids Res. 1993 Jan 11;21(1):151-4 PMID: 8441609
  8. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region.
    J Mol Biol. 1993 Mar 5;230(1):90-110 PMID: 8450553
  9. Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function.
    J Virol. 1993 Jul;67(7):3703-11 PMID: 8389901
  10. Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.
    J Virol. 1993 Sep;67(9):5617-22 PMID: 8350414
  11. A circular trans-acting hepatitis delta virus ribozyme.
    Nucleic Acids Res. 1993 Sep 11;21(18):4253-8 PMID: 7692400
  12. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication.
    Cell. 1990 Nov 2;63(3):601-8 PMID: 2225067
  13. HIV-1 Tat protein trans-activates transcription in vitro.
    Cell. 1990 Nov 16;63(4):791-802 PMID: 2225077
  14. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.
    Genes Dev. 1990 Aug;4(8):1365-73 PMID: 2227414
  15. Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.
    Proc Natl Acad Sci U S A. 1990 Nov;87(22):8985-9 PMID: 2247474
  16. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.
    Genes Dev. 1991 Feb;5(2):201-10 PMID: 1899841
  17. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR.
    Science. 1991 Mar 29;251(5001):1597-600 PMID: 2011739
  18. Arginine-mediated RNA recognition: the arginine fork.
    Science. 1991 May 24;252(5009):1167-71 PMID: 1709522
  19. Refolded HIV-1 tat protein protects both bulge and loop nucleotides in TAR RNA from ribonucleolytic cleavage.
    Biochemistry. 1991 Aug 13;30(32):8060-6 PMID: 1868081
  20. RNA recognition by Tat-derived peptides: interaction in the major groove?
    Cell. 1991 Aug 9;66(3):577-88 PMID: 1907891
  21. Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein.
    J Virol. 1991 Oct;65(10):5196-202 PMID: 1895380
  22. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
    Genes Dev. 1991 Nov;5(11):2128-40 PMID: 1936997
  23. Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin.
    Genes Dev. 1991 Dec;5(12B):2508-20 PMID: 1752441
  24. Unusual structure of the human immunodeficiency virus type 1 trans-activation response element.
    J Virol. 1992 Feb;66(2):930-5 PMID: 1731114
  25. Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells.
    J Virol. 1992 Jul;66(7):4617-21 PMID: 1602563
  26. Conformation of the TAR RNA-arginine complex by NMR spectroscopy.
    Science. 1992 Jul 3;257(5066):76-80 PMID: 1621097
  27. RNA binding assays for Tat-derived peptides: implications for specificity.
    Biochemistry. 1992 Oct 27;31(42):10281-7 PMID: 1384694
  28. Group I permuted intron-exon (PIE) sequences self-splice to produce circular exons.
    Nucleic Acids Res. 1992 Oct 25;20(20):5357-64 PMID: 1279519
  29. HIV-1 TAR RNA-binding proteins control TAT activation of translation in Xenopus oocytes.
    FASEB J. 1993 Jan;7(1):214-22 PMID: 8422967
  30. Separation and characterization of factors mediating accurate transcription by RNA polymerase II.
    J Biol Chem. 1982 Dec 10;257(23):14419-27 PMID: 7142220
  31. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
    Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 PMID: 6828386
  32. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).
    Science. 1985 Jul 5;229(4708):69-73 PMID: 2990040
  33. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.
    Cell. 1986 Sep 26;46(7):973-82 PMID: 3530501
  34. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein.
    Cell. 1987 Feb 27;48(4):691-701 PMID: 3643816
  35. Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat.
    J Virol. 1988 Mar;62(3):673-9 PMID: 2828663
  36. ompT encodes the Escherichia coli outer membrane protease that cleaves T7 RNA polymerase during purification.
    J Bacteriol. 1988 Mar;170(3):1245-53 PMID: 3277950
  37. HIV-1 tat trans-activation requires the loop sequence within tar.
    Nature. 1988 Jul 14;334(6178):165-7 PMID: 3386755
  38. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells.
    Gene. 1988 Jun 15;66(1):1-10 PMID: 3417148
  39. Stability of RNA in developing Xenopus embryos and identification of a destabilizing sequence in TFIIIA messenger RNA.
    Development. 1988 Apr;102(4):837-52 PMID: 2458900
  40. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation.
    EMBO J. 1989 Mar;8(3):765-78 PMID: 2721501
  41. Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.
    Proc Natl Acad Sci U S A. 1989 Sep;86(18):6925-9 PMID: 2476805
  42. Tat trans-activates the human immunodeficiency virus through a nascent RNA target.
    Cell. 1989 Oct 20;59(2):273-82 PMID: 2478293
  43. Synthesis of small RNAs using T7 RNA polymerase.
    Methods Enzymol. 1989;180:51-62 PMID: 2482430
  44. Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence.
    J Virol. 1990 Mar;64(3):1402-6 PMID: 2406460
  45. An NMR study of the HIV-1 TAR element hairpin.
    Biochemistry. 1993 Nov 23;32(46):12522-30 PMID: 8241143
  46. Structural characteristics of the stable RNA introns of archaeal hyperthermophiles and their splicing junctions.
    J Mol Biol. 1994 Nov 11;243(5):846-55 PMID: 7966305
  47. Control of RNA initiation and elongation at the HIV-1 promoter.
    Annu Rev Biochem. 1994;63:717-43 PMID: 7979253
  48. Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors.
    J Virol. 1995 May;69(5):3098-107 PMID: 7707538
  49. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
    Nature. 1990 Jun 14;345(6276):640-2 PMID: 2190099
Article Info
Journal
Nucleic acids research
Abbr.
Nucleic Acids Res
ISSN
0305-1048
Published
1996-10-01
Pages
3733-8
Language
English
Region
England
NLM ID
0411011
PMCID
PMC146173
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]